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Abstract
Background: There is conflicting evidence about the relationship between the dose of enteral caloric intake and
survival in critically ill patients. The objective of this systematic review and meta-analysis is to compare the effect of
lower versus higher dose of enteral caloric intake in adult critically ill patients on outcome.
Methods: We reviewed MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of
Systematic Reviews, and Scopus from inception through November 2015. We included randomized and quasi-
randomized studies in which there was a significant difference in the caloric intake in adult critically ill patients,
including trials in which caloric restriction was the primary intervention (caloric restriction trials) and those with
other interventions (non-caloric restriction trials). Two reviewers independently extracted data on study characteristics,
caloric intake, and outcomes with hospital mortality being the primary outcome.
Results: Twenty-one trials mostly with moderate bias risk were included (2365 patients in the lower caloric intake
group and 2352 patients in the higher caloric group). Lower compared with higher caloric intake was not associated
with difference in hospital mortality (risk ratio (RR) 0.953; 95 % confidence interval (CI) 0.838–1.083), ICU mortality (RR 0.
885; 95 % CI 0.751–1.042), total nosocomial infections (RR 0.982; 95 % CI 0.878–1.077), mechanical ventilation duration,
or length of ICU or hospital stay. Blood stream infections (11 trials; RR 0.718; 95 % CI 0.519–0.994) and incident renal
replacement therapy (five trials; RR 0.711; 95 % CI 0.545–0.928) were lower with lower caloric intake. The associations
between lower compared with higher caloric intake and primary and secondary outcomes, including pneumonia, were
not different between caloric restriction and non-caloric restriction trials, except for the hospital stay which was longer
with lower caloric intake in the caloric restriction trials.
Conclusions: We found no association between the dose of caloric intake in adult critically ill patients and hospital
mortality. Lower caloric intake was associated with lower risk of blood stream infections and incident renal
replacement therapy (five trials only). The heterogeneity in the design, feeding route and timing and caloric dose
among the included trials could limit our interpretation. Further studies are needed to clarify our findings.
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Background
Nutritional support is essential in the management of
adult critically ill patients [1, 2]. Supported by random-
ized controlled trials (RCTs) and systematic reviews [2],
early initiation of enteral nutrition (EN) has been shown
to be associated with better outcome compared to late
EN. However, it is less clear what the most appropriate
caloric dose is. Based on expert opinion, observational
studies and small RCTs [3–7], it has been generally rec-
ommended to provide full caloric requirement to critically
ill patients [8]. To achieve this goal, interventions to aug-
ment caloric intake, such as the implementation of proto-
cols [9, 10], prokineteic agents and postpyloric tube
placement [11] have been proposed, even though studies
have not demonstrated improvement in clinical outcomes.
On the contrary, several observational studies observed
better outcome with lower enteral caloric intake [12, 13].
These conflicting results may be related to differences
in study populations, selection bias and immortal time
bias (nutritional intake is better for patients who survive
and have a longer ICU stay). Prescribed hypocaloric nu-
trition has recently been tested in several randomized
controlled studies [14–16]. Although parenteral nutrition
(PN) differs from EN in indications, physiologic effects
and complications, studies have shown that lower caloric
intake with PN was associated with better clinical out-
comes [17]. As such the clinical practice guidelines of the
Society of Critical Care Medicine and American Society
for Parenteral and Enteral Nutrition recommended that
mild permissive underfeeding should be considered in
critically ill patients receiving PN, at least in certain high-
risk groups [8, 18]. On the other hand, the evidence on
the relationship between enteral caloric intake and sur-
vival remains conflicting and has ignited heated discussion
in the critical care literature [19, 20].
Given the present controversies, a systematic review
that includes RCTs is likely to produce more reliable ef-
fect estimates. Therefore, we conducted this systematic
review and meta-analysis to compare the impact of lower
versus higher dose of enteral caloric intake in adult critically
ill patients on mortality and other important outcomes.
Methods
This systematic review is reported according to the state-
ment of Preferred Reporting Items for Systematic Reviews
and Meta-analyses (PRISMA) [21].
Literature search
We conducted a comprehensive search of several data-
bases from the earliest inception of each database to No-
vember 2015 for randomized trials examining the effect of
EN dose on the outcomes of critically ill patients. The da-
tabases included Ovid Medline In-Process and Other
Non-Indexed Citations, Ovid MEDLINE, Ovid EMBASE,
Ovid Cochrane Central Register of Controlled Trials, Ovid
Cochrane Database of Systematic Reviews, and Scopus.
The search strategy was designed and conducted by an ex-
perienced librarian. The detailed search strategy including
that of Scopus is presented in Additional file 1.
We also conducted a manual search of the bibliograph-
ies of all selected articles, systematic reviews on nutritional
support in critically ill patients and studies published as
abstracts in the preceding five meetings of the American
Thoracic Society (2010–2015), Society of Critical Care
Medicine (2010–2015), American College of Chest Physi-
cians (2010–2015), American Society for Parenteral and
Enteral Nutrition (2010–2015) and European Society for
Parenteral and Enteral Nutrition (2010–2015).
Study selection
Two authors (YA and HD) independently assessed the
titles and abstracts from the search results for eligibility.
We included studies that met the following criteria: (1)
randomized or quasi-randomized design; (2) enrolled
adults who were critically ill and required care in an
ICU setting; (3) primarily compared two doses of EN; (4)
reported caloric intake either in absolute values (i.e., in
kcal) or in percentage of caloric requirement as defined
by authors; and (5) had a meaningful difference in cal-
oric intake between the two groups (statistically signifi-
cant or if the difference was ≥10 %). The 10 % difference
was defined a priori by the authors of this review as the
minimally significant difference.
We excluded studies: (1) of PN as a primary interven-
tion; (2) that compared early versus late EN; (3) that
assessed enteral formulae that had immune-modulating
ingredients; (4) that evaluated postpyloric placement of
the feeding tube for gastrointestinal reasons (such as
pancreatitis) and not primarily to increase caloric intake;
(5) that were cluster randomized or crossover studies;
(6) that were trials with only surrogate outcomes (such
as nutritional, biochemical, economic or quality of life
assessment endpoints); and (7) that were trials published
in abstract form only or in a non-English language.
The included trials in this systematic review fell in one
of two categories. The first category was studies that had
caloric restriction as the primary intervention defined as
deliberate reduction of caloric intake from the estimated
requirement. In these studies, which we refer to in the
rest of the paper as caloric restriction trials, the lower
dose included trophic feeding (minimal amounts of calo-
ries, i.e., 20 kcal/h) [15, 16] and hypocaloric feeding or
permissive underfeeding (moderate amount of calories,
i.e., close to 50 % of caloric requirement) [14, 22, 23]. In
these trials, the higher dose was standard or eucaloric
feeding (usually 70–100 % of caloric need) [14–16, 22, 23].
The second category, which we referred to as non-caloric
restriction trials, included studies in which an intervention
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was tested that led directly or indirectly to change in
caloric intake. These interventions included, but were
not limited to, protocol implementation, postpyloric tube
placement and the use of prokinetics. We resolved differ-
ences by discussion. All potentially eligible studies were
retrieved in full.
Risk of bias assessment
Two reviewers (HD and YA) independently assessed the
methodological quality of each trial using the Cochrane
Collaboration tool for Assessing Risk of Bias [24]. Any
discrepancies between the two reviewers were resolved
through discussion. The measure of agreement between
reviewers was calculated using kappa statistics.
Data extraction
Two non-blinded reviewers (HD and AB) independently
abstracted pertinent data from the trials using a standard-
ized predefined form. Extracted data included study de-
sign, study size, study setting, patient population, reported
illness severity score, interventions and their duration and
caloric intake (mean and percentage of estimated caloric
target) in each arm. The primary outcome of this review
was all-cause hospital mortality. Other important out-
comes were chosen a priori and included ICU mortality,
bloodstream infection as defined by the authors, pneumo-
nia as defined by the authors, all infections, incident or
new renal replacement therapy, mechanical ventilation
duration and ICU and hospital length of stay (LOS).
For published reports with insufficient information, we
attempted to contact the corresponding author for
clarification. Two authors replied and the two studies
were later excluded.
Statistical analysis
From each study, we extracted the number of events and
sample size in each arm (binary outcomes) and the mean
with a measure of variability (continuous outcomes). Meta-
analysis was performed using the random-effects model as
described by DerSimonian and Laird [25]. The pooled-
effect estimates of lower versus higher caloric intake were
reported as risk ratio (RR) and weighted mean difference
(WMD) with 95 % confidence intervals (CIs).
We performed subgroup analyses with stratification by
caloric restriction versus non-caloric-restriction trials
which had mean patients’ age <65 versus those with mean
age ≥65 years, trials which had mean Acute Physiology and
Chronic Health Evaluation (APACHE) II score <20 versus
those with mean APACHE II ≥20, trials in which the lower
calorie group received <60 % versus those in which the
lower calorie group received ≥60 % of requirement and tri-
als in which the calorie difference between the two groups
<20% versus those with the difference ≥20 %. We tested
for interaction between the subgroups and considered the
interaction test to be significant when its p value was
<0.05. We also conducted meta-regression to assess the ef-
fect of the difference in caloric intake between the arms in
each study and of the amount of provided calories in the
lower calorie group in each study on hospital mortality.
All statistical tests were two-sided and a p value <0.05
was considered statistically significant. The degree of
heterogeneity among the studies was assessed by the I2
statistic [26]. Between-study heterogeneity was consid-
ered low if I2 was <30 % whereas I2 >50 % represented
substantial heterogeneity. A small study bias or publica-
tion bias was assessed by visual inspection of the funnel
plot and by conducting the Egger regression test. We used
the Comprehensive Meta analysis Software (Version 3,
Englewood, NJ, USA) for all analyses.
Results
Figure 1 shows the flow chart of the study selection
process. Through the electronic database search, we identi-
fied 449 citations. We excluded 413 studies after screening
the titles and abstracts. The manual search of abstracts
from conferences and of bibliographies yielded 12 add-
itional studies that met the inclusion criteria. The full texts
of 50 studies were evaluated and 29 studies were excluded
[9, 10, 27–53] for different reasons as shown in Fig. 1.
Twenty-one studies were eligible for data extraction and
analysis [14–16, 22, 23, 54–69]. We followed the intention-
to-treat principle whenever possible.
Description of included studies
A summary of the included studies is presented in
Table 1. The total sample size was 4717 patients (2365
in the lower caloric intake group and 2352 in the high
caloric group). Seven studies [14–16, 22, 23, 68, 69] dir-
ectly compared caloric restriction provided by enteral
tube feeding with standard feeding and 14 assessed the
effect of an intervention that led to a significant differ-
ence in caloric intake. The mean difference in caloric in-
take was 445 kcal (range 165–1118 kcal). The difference
in calories between the intervention groups corre-
sponded to 14–78.8 % of the higher caloric intake.
Table 2 describes the risk of bias assessment of the
studies and shows that most studies had bias risk in at
least one domain of the Cochrane Collaboration tool. All
except two studies [57, 66] were un-blinded. Agreement
between reviewers (kappa) on the tool elements was 0.774
(95 % CI 0.651–0.892; p < 0.001).
Effect on mortality
Nineteen studies provided data on hospital mortality
[14–16, 22, 54, 55, 57–69]. Figure 2a describes the corre-
sponding forest plot. Lower compared with higher cal-
oric intake was not associated with difference in hospital
mortality; the overall RR was 0.953 (95 % CI, 0.838–
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1.083). The association between lower compared with
higher caloric intake and hospital mortality was not
different between caloric restriction [14–16, 22, 68, 69]
and non-caloric restriction trials [54, 55, 57–67] (inter-
action test p = 0.19).
Similarly, the association between lower compared with
higher caloric intake and hospital mortality was not
different between studies in which the mean age of
patients was ≥65 years [59, 64] and those in which the
mean age was <65 years [14–16, 22, 54, 55, 57, 58, 60–63,
65–69] (RR 0.994; 95 % CI 0.825–1.079; interaction test
p = 0.54), between studies in which the mean APACHE
II score was <20 [22, 61, 62, 69], and those in which the
mean APACHE II score was ≥20 [14, 15, 54, 55, 57, 59,
60, 63, 64, 66–68] (RR 0.977; 95 % CI 0.862–1.108;
interaction test p = 0.73), between studies [14–16, 22,
54, 68, 69] where the lower calorie group received
<60 % of requirement and studies where the lower
calorie group received ≥60 % [55, 57–67] (RR 0.946;
95 % CI 0.832–1.075; interaction test p = 0.20) and between
the studies in which the calorie difference between the two
groups ≥20 % [15, 16, 22, 55, 66–69] and those with calorie
difference <20 % [14, 58, 60, 62, 64] (RR 0.977; 95 % CI
0.860–1.110; interaction test p = 0.97).
The meta-regression analysis (Fig. 2b and c) showed
that hospital mortality was not influenced by the differ-
ence in caloric intake between the lower and higher calorie
groups in each trial (slope = -0.0002; p = 0.56) or by the
lower caloric dose in each trial (slope = 0.0001; p = 0.69).
Additionally, there was low heterogeneity among the
studies (I2 = 26.4 %) and no evidence of publication bias on
inspection of the funnel plot (Fig. 2d), with p = 0.79 for
Egger’s test.
Eight studies had data on ICU mortality. Figure 3
presents the corresponding forest plot. The overall RR
was 0.885 (95 % CI 0.751–1.042). There was no significant
difference between caloric restriction and non-caloric-
restriction trials (interaction test p = 0.32). There was no



























Additional records identified 
through other sources
(n = 12)









Excluded full-text articles with 
reasons
(n = 29) [9, 10, 27-53]
2 Chinese language [45, 50]
2 not in ICU setting [28, 48]
8 no difference in calories [30,
35-39, 42, 43]
1 parenteral nutrition 
contributed to high % of 
caloric intake [53]
3 cluster randomized trials [9, 
10, 49]
8 no calorie data [27, 30, 34,
41, 44, 46, 47, 52]
2 no outcome data [31, 51]
1 observational study [33]
1 feeding for short duration (4 
hours) [32]
1 significant difference in 
caloric intake for only short 
duration (2 days) [40]
Studies included in 
qualitative synthesis
(n = 21)




Fig. 1 Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flow diagram
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Table 1 Characteristics of studies included in the systematic review
Author, year Population Design Number of
patients
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intervention group,
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46.9 ± 25.9 % of goal)
Gastric feeding
(1466 ± 398 kcal;
61.0 ± 17 % of
goal)












68 22 in the intervention
group, 20 in the
control group
100 % Small intestinal feeding
(1157 ± 86 kcal; 18 ±
1 kcal/kg/day; 69 ± 7 %
of caloric requirement)
Protein intake: 0.7 ±
0.1 g/kg/kg/day
Gastric feeding
(812 ± 122 kcal;
12 ± 2 kcal/kg/day;
47 ± 7 % of caloric
requirement).
Protein intake
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distribution in both
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intervention,
67.9 years in the
control group
70.2 20.5 in the
intervention group,
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100 % Nasoduodenal feeding
group (1658 ± 118 kcal;
27.1 ± 7.6 kcal/kg/day)




110 kcal; 23.5 ±
8.8 kcal/kg/day)












50 30 in the intervention
group, 24.5 in the
control group
100 % Postpyloric feeding




















RCT 329 65 years in the
intervention
group, 60 years
65 19.4 in the
intervention group,
100 % High gastric residual
volume of 500 ml
Low gastric residual













Table 1 Characteristics of studies included in the systematic review (Continued)
in the control
group
18.9 in the control
group
(diet volume ratio in
the first week = 88.2 %)





et al., 2010 [62]a
Severe traumatic
brain injury





86.5 16 in the intervention
group, 18 in the
control group
100 % Transpyloric feeding
(92 % of the feeding
volume given)
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group
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26.9 % of target
Nasogastric feeding
(1343 kcal; 76.2 % of
target energy intake)
Protein intake 78.6 ±











70 Baseline SOFA 8 for
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74 23 in the intervention
group, 22 in the
control group
100 % Nutritional formula
1.5 kcal/ml (1832 ±
381 kcal; 27.3 ±
7.4 kcal/kg; 96.0 %
of requirement)
Protein intake
75 % of target
Nutritional formula
1 kcal/ml (1259 ±
428 kcal; 19.0 ±
6.0 kcal/kg; 68.4 %
of requirement)










71 16.6 in the
intervention group,
17.3 in the control
group
62.7 % Hypocaloric feeding:
50 % of estimated
requirement as 12.5-
15 kcal/kg/day
(982 ± 61 kcal;




100 % of estimated
requirement as
25–30 kcal/kg/day
(1338 ± 92 kcal;
















51.2 23.4 in the
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70–100 % of caloric
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467 kcal; 71 % of
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RCT 331 59 years in the
intervention group,
61 years in the
control group
58.6 18 in the intervention
and control groups
91 % Protocolized caloric
restriction 20 kcal/h







At least 4 days
aProtein intake not reported. APACHE Acute Physiology and Chronic Health Evaluation, ARDS acute respiratory distress syndrome, MV mechanical ventilation, RCT randomized controlled trial, SAPS Simplified Acute










Table 2 Quality of included randomized controlled trials using the Cochrane Collaboration tool for assessing risk of bias
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Not described Not described No No No No Two ICUs 0 Not reported
Hsu et al.,
2009 [59]





Computer generated Yes (sealed opaque
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No Yes No No Single 0 Not reported
Montejo et al.,
2010 [61]
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et al., 2010 [62]
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significant heterogeneity among the studies (I2 = 0 %) and
no evidence of publication bias (Egger’s test p = 0.40).
Effect on infections
Twelve studies reported data on more than one infection
[14–16, 22, 54, 55, 62, 63, 65, 67–69]. Figure 4 describes
the corresponding forest plot. The overall RR was 0.972
(95 % CI, 0.878–1.077) with no significant difference be-
tween caloric restriction and non-caloric-restriction tri-
als (interaction test p = 0.91). The overall heterogeneity
was low (I2 = 25.7 %).
Eleven studies collected data on bloodstream infec-
tions [14, 16, 22, 54, 55, 59, 62, 63, 65, 68, 69] and
showed lower risk of such infections in the lower versus
higher caloric intake groups (RR 0.718; 95 % CI 0.519–
0.994; Fig. 5a). The interaction test between caloric re-
striction and non-caloric-restriction trials was not signifi-
cant (p = 0.48). Meta-regression showed no association
between bloodstream infection risk and the amount of
calorie intake in the difference in caloric intake between the
intervention groups in each trial (slope = 0.0001; p = 0.75)
and the lower calorie group in each trial (slope = -0.0002;
p = 0.30) (Fig. 5b and c). There was low heterogeneity
among the studies (I2 = 26.7 %). The funnel plot (Fig. 5d)
showed possible publication bias (Egger’s test p = 0.04).
Fifteen studies reported data on development of pneu-
monia [14–16, 22, 54–56, 59–63, 65, 68, 69]. Figure 6
presents the related forest plot. The overall RR was
0.920 (95 % CI 0.784–1.080) with no significant difference
between caloric restriction and non-caloric-restriction
trials (interaction test p = 0.88). There was substantial
heterogeneity among the studies (I2 = 53.8 %).
Effect on incident renal replacement therapy
Five studies reported data on incident renal replacement
therapy [14, 63, 65, 68, 69]. The overall RR was 0.711
(95 % CI 0.545–0.928) (Fig. 7a) with no significant differ-
ence between caloric restriction and non-caloric-restriction
trials (test of interaction p = 0.33). The meta-regression
(Fig. 7b and c) showed significant association between
incident renal replacement therapy and the difference in
caloric intake between the lower and higher calorie groups
in each study (slope = -0.0009; p = 0.02) and the lower
Meta Analysis
Group A: Studies that did not test calorie restriction as an intervention. 
Group B: Studies that tested calorie restriction versus standard feeding strategy.
I2 for Group A studies: 15.0%
I2 for Group B studies: 41.1%
Overall I2: 26.4%
Study name Statistics for each study Events / Total Risk ratio and 95% CI
Risk Lower Upper Relative 
ratio limit limit p-Value low high weight
Montecalvo et al, 1992 1.000 0.345 2.898 1.000 5 / 19 5 / 19 2.37
Kearns et al, 2000 1.096 0.392 3.066 0.862 6 / 23 5 / 21 2.53
Nguyen et al, 2007 1.217 0.540 2.742 0.635 10 / 38 8 / 37 3.95
Desachy et al, 2008 0.786 0.396 1.560 0.491 11 / 50 14 / 50 5.38
Hsu et al, 2009 0.878 0.574 1.344 0.550 24 / 62 26 / 59 12.05
White et al, 2009 2.459 0.916 6.600 0.074 11 / 51 5 / 57 2.74
Montejo et al, 2010 0.987 0.726 1.343 0.936 55 / 165 53 / 157 19.12
Acosta-Escribano et al, 2010 1.389 0.532 3.623 0.502 9 / 54 6 / 50 2.89
Singer et al, 2011 1.476 0.956 2.279 0.079 31 / 65 21 / 65 11.66
Huang et al, 2012 0.833 0.498 1.396 0.488 17 / 51 20 / 50 8.83
Reignier et al, 2013 0.990 0.734 1.336 0.948 61 / 222 63 / 227 19.77
Peake et al, 2014 1.451 0.705 2.987 0.312 14 / 55 10 / 57 4.90
Braunschweig et al, 2015 0.395 0.173 0.902 0.028 6 / 38 16 / 40 3.82
1.023 0.866 1.210 0.786
Arabi et al, 2011 0.706 0.501 0.995 0.047 36 / 120 51 / 120 19.67
Rice et al, 2011 1.145 0.668 1.961 0.622 22 / 98 20 / 102 10.77
EDEN trial, 2012 1.048 0.834 1.318 0.685 118 / 508 109 / 492 28.75
Charles et al, 2014 0.768 0.183 3.223 0.719 3 / 41 4 / 42 1.91
Arabi et al, 2015 0.874 0.700 1.092 0.236 108 / 447 123 / 445 29.34
Doig et al, 2015 0.497 0.278 0.889 0.018 15 / 166 30 / 165 9.56
























Overall 0.953 0.838 1.084 0.466





Regression of Log risk ratio on the difference in caloric intake  
Difference in caloric intake (kcal)  
Regression of Log risk ratio on the lower caloric intake  
Lower caloric intake (kcal)  
a b
c d
Fig. 2 Hospital mortality. a Pooled risk ratio with 95 % confidence interval (CI) for hospital mortality, association with lower versus higher dose of
enteral feeding. The random effects model was used. b Meta-regression for the effect of the difference in calories between the lower and higher
caloric intake groups in each trial on hospital mortality. c Meta-regression for the effect of the caloric dose in the lower caloric intake group in each trial
on hospital mortality. d Funnel plot for the corresponding studies
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I2 for Group A studies: 54.4%
I2 for Group B studies: 0%
Overall I2: 25.7%
Group A: Studies that did not test calorie restriction as an intervention. 
Group B: Studies that tested calorie restriction versus standard feeding strategy.
Group by
Comparison
Study name Statistics for each study Events / Total Risk ratio and 95% CI
Risk Lower Upper Relative 
ratio limit limit p-Value low high weight
A Montecalvo et al, 1992 0.833 0.306 2.270 0.721 5 / 19 6 / 19 7.53
A Kearns et al, 2000 1.043 0.458 2.379 0.919 8 / 23 7 / 21 10.12
A Acosta-Escribano et al, 2010 1.213 0.906 1.626 0.195 38 / 54 29 / 50 27.10
A Singer et al, 2011 0.541 0.355 0.824 0.004 20 / 65 37 / 65 21.50
A Reignier et al, 2013 1.023 0.753 1.389 0.887 60 / 222 60 / 227 26.49
A Braunschweig et al, 2015 1.684 0.604 4.696 0.319 8 / 38 5 / 40 7.26
A 0.955 0.701 1.302 0.773
B Arabi et al, 2011 0.946 0.717 1.249 0.697 53 / 120 56 / 120 15.12
B Rice et al, 2011 0.946 0.628 1.425 0.791 30 / 98 33 / 102 6.95
B EDEN trial, 2012 1.169 0.913 1.496 0.216 111 / 508 92 / 492 19.11
B Charles et al, 2014 0.928 0.716 1.203 0.574 29 / 41 32 / 42 17.30
B Arabi et al, 2015 0.948 0.799 1.126 0.545 161 / 447 169 / 445 39.69
B Doig et al, 2015 0.596 0.269 1.324 0.204 9 / 166 15 / 165 1.83
B 0.975 0.875 1.086 0.640
Overall 0.972 0.878 1.077 0.591
0.01 0.1 1 10 100
Meta Analysis
Favors lower caloric 
intake
Favors higher caloric 
intake
Fig. 4 Pooled risk ratio with 95 % confidence interval (CI) for total infections associated with lower versus higher dose of enteral feeding. The
random effects model was used
I2 for Group A studies: 0%
I2 for Group B studies: 0%
Overall I2: 0%
Group A: Studies that did not test calorie restriction as an intervention. 
Group B: Studies that tested calorie restriction versus standard feeding strategy.
Group by
Comparison
Study name Statistics for each study Events / Total
Risk ratio and 95% CI
Risk Lower Upper Relative 
ratio limit limit p-Value low high weight
A Desachy et al, 2008 1.333 0.499 3.564 0.566 8 / 50 6 / 50 5.22
A Montejo et al, 2010 0.798 0.497 1.281 0.350 26 / 165 31 / 157 22.52
A Singer et al, 2011 1.063 0.589 1.916 0.840 17 / 65 16 / 65 14.50
A Reignier et al, 2013 0.924 0.677 1.260 0.616 56 / 222 62 / 227 52.35
A Peake et al, 2014 1.555 0.593 4.077 0.370 9 / 55 6 / 57 5.42
A 0.956 0.764 1.197 0.696
B Arabi et al, 2011 0.808 0.482 1.354 0.418 21 / 120 26 / 120 21.29
B Arabi et al, 2015 0.843 0.634 1.122 0.241 72 / 447 85 / 445 69.80
B Doig et al, 2015 0.596 0.269 1.324 0.204 9 / 166 15 / 165 8.92
B 0.810 0.638 1.028 0.083
Overall 0.885 0.751 1.042 0.141
0.01 0.1 1 10 100
Meta Analysis
Favors lower caloric 
intake
Favors higher caloric 
intake
Fig. 3 Pooled risk ratio with 95 % confidence interval (CI) for intensive care unit mortality associated with lower versus higher dose of enteral
feeding. The random effects model was used
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caloric dose in each study (slope = -0.0004; p = 0.02). There
was low heterogeneity (I2 = 0 %) with the funnel plot
shown in Fig. 7d (Egger’s test p = 0.17).
Effect on length of stay
Eleven studies provided data (means with standard devi-
ations) on hospital LOS [14, 22, 55, 57–60, 62, 67–69].
The pooled analysis showed no difference in hospital
stay (WMD= +1.11 days; 95 % CI -1.09–3.30 days)
(Fig. 8). However, the association of lower versus higher
caloric intake and hospital LOS was different between cal-
oric restriction and non-caloric-restriction trials (interaction
test p= 0.005). In the caloric restriction trials, the hospital
LOS was longer with lower compared with higher caloric in-
take (WMD=+4.09 days; 95 % CI 1.08–7.11 days), whereas
it was not different between lower and higher dose caloric
intake in the non-caloric restriction trials (Fig. 8). There was
substantial heterogeneity among the studies (I2 = 76.3 %).
However, there was no evidence of publication bias (Egger’s
test p = 0.11). Meta-regression analysis showed that the
hospital LOS was not influenced by the difference in
caloric intake between the lower and higher calorie groups
in each trial or by the lower calorie dose in each trial.
Fourteen studies provided data on ICU LOS [14, 22,
23, 54, 55, 58, 59, 61–64, 67–69] with no significant dif-
ference between the lower and higher caloric intake groups
(WMD= -0.13 days (95 % CI -1.45–1.19 days) (Fig. 9). The
association between lower compared with higher caloric
intake and ICU LOS was not different between caloric
restriction and non-caloric-restriction trials (test of
interaction p = 0.39). There was a substantial hetero-
geneity among the studies (I2 = 78.0 %). Egger’s test p
was 0.07.
Eight studies had data on duration of mechanical ven-
tilation [14, 23, 54, 59, 62, 63, 68, 69]. The meta-analysis
found no difference (Fig. 10) with WMD= -1.12 days
(95 % CI -2.67– 0.44 days). There was substantial hetero-
geneity among the studies (I2 = 69.7 %). The association
between lower compared with higher caloric intake and
mechanical ventilation duration was not different between
caloric restriction and non-caloric-restriction trials (test of
interaction p = 0.89). The Egger’s test p value was 0.09,
suggesting insignificant publication bias.
Discussion
In this systematic review and meta-analysis of RCTs of
critically ill patients in which there was a significant
Group A: Studies that did not test calorie restriction as an intervention. 
Group B: Studies that tested calorie restriction versus standard feeding strategy.
I2 for  Group A studies: 0%








Study name Statistics for each study Events / Total Risk ratio and 95% CI
Risk Lower Upper Relative 
ratio limit limit p-Value low high weight
A Montecalvo et al, 1992 0.667 0.223 1.990 0.467 4 / 19 6 / 19 15.52
A Kearns et al, 2000 1.522 0.413 5.603 0.528 5 / 23 3 / 21 10.93
A Hsu et al, 2009 0.952 0.200 4.529 0.950 3 / 62 3 / 59 7.63
A Acosta-Escribano et al, 2010 0.309 0.065 1.459 0.138 2 / 54 6 / 50 7.69
A Singer et al, 2011 0.615 0.274 1.385 0.241 8 / 65 13 / 65 28.23
A Reignier et al, 2013 0.541 0.247 1.189 0.126 9 / 222 17 / 227 30.01
A 0.649 0.422 0.998 0.049
B Arabi et al, 2011 0.590 0.220 1.581 0.294 6 / 120 10 / 120 15.79
B EDEN trial, 2012 1.242 0.862 1.789 0.244 59 / 508 46 / 492 34.40
B Charles et al, 2014 1.280 0.562 2.919 0.557 10 / 41 8 / 42 19.46
B Arabi et al, 2015 0.576 0.278 1.197 0.139 11 / 447 19 / 445 22.00
B Doig et al, 2015 0.248 0.054 1.153 0.075 2 / 166 8 / 165 8.34
B 0.820 0.500 1.345 0.433
Overall 0.718 0.519 0.994 0.046
0.01 0.1 1 10 100
Meta Analysis Regression of Log risk ratio on the difference in caloric intake  
Difference in caloric intake (kcal) 
Regression of Log risk ratio on the lower caloric intake  
Lower caloric intake (kcal) 
a b
c d
Fig. 5 Blood stream infection. a Pooled risk ratio with 95 % confidence interval (CI) for hospital mortality associated with lower versus higher
dose of enteral feeding. The random effects model was used. b Meta-regression for the effect of the difference in calories between the lower and
higher caloric intake groups on hospital mortality. c Meta-regression for the effect of the caloric dose in the lower caloric intake group on hospital
mortality. d Funnel plot for the corresponding studies
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difference in the caloric intake via EN, we found that
lower versus higher dose of caloric intake was not asso-
ciated with mortality. However, patients in the lower
caloric intake group had lower risk of blood stream in-
fections and incident renal replacement therapy. The as-
sociations between lower compared with higher caloric
intake and all studied outcomes were not different be-
tween caloric restriction and non-caloric restriction trials,
except for the hospital LOS. Our certainty in the meta-
analytic estimates is reduced due to the moderate risk of
bias.
The optimal EN dose during critical illness is un-
known. Malnourishment is generally associated with
poor outcomes leading to the notion that replacement of
full energy needs is intuitively needed. However, in crit-
ically ill patients, multiple metabolic changes may occur
and differ from one patient to another. The metabolic
rate is highly variable, being increased in about 50 % of
patients but low in others [70]. Glycolysis is increased as
the energy source is altered from predominantly fat to
glucose oxidation [71]. Proteolysis is accelerated espe-
cially as prolonged starvation is associated with dysregu-
lated metabolism, such that major stimulation of both
ketogenesis and concomitant gluconeogenesis do not
occur [72]. The normal suppression of lipolysis and pro-
teolysis by the exogenous supply of fat or carbohydrates
is blunted [71]. Additionally, excess caloric provision
might be detrimental, particularly to the mitochondria
by increasing oxygen radical production [73], and full
EN may lead to gastrointestinal intolerance, which may
increase infection risk. On the other hand, caloric re-
striction may enhance autophagy, which might be pro-
tective [74, 75]. These changes have led to the premise
that lower caloric intake may have a protective effect.
The available studies on this topic produced mixed re-
sults. In this meta-analysis of RCTs in which critically ill
patients received significantly different caloric intake, we
found no difference in the primary outcome of hospital
mortality. The results were similar in caloric restriction
and non-caloric restriction trials and when studies were
stratified based on age, severity of illness, amount of calo-
ries in the lower calorie group and the difference in calories
between the intervention groups. Moreover, there was no
clear dose–effect relationship as observed in the meta-
regression. Marik and Hooper have recently published a
systematic review and meta-analysis of six trials that
assessed the outcomes of ICU patients randomized to ei-
ther normocaloric or hypocaloric feeding and also found
no difference in mortality and infectious complications
[76]. However, our study differed in its inclusion and exclu-
sion criteria and thus included 21 trials, which evaluated
various interventions that resulted in different caloric in-
take. We also analyzed multiple subgroups and performed
meta-regression.
I2 for Group Astudies:70.7 %
I2 for Group B studies: 0%
Overall I2: 53.8%
Group A: Studies that did not test calorie restriction as an intervention. 




Study name Statistics for each study Events / Total Risk ratio and 95% CI
Risk Lower Upper Relative 
ratio limit limit p-Value low high weight
A Montecalvo et al, 1992 5.000 0.256 97.697 0.289 2 / 19 0 / 19 0.32
A Kearns et al, 2000 0.685 0.173 2.709 0.589 3 / 23 4 / 21 1.51
A Chen et al, 2006 0.595 0.445 0.795 A0 26 / 51 48 / 56 34.15
A Hsu et al, 2009 2.855 1.107 7.362 0.030 15 / 62 5 / 59 3.19
A White et al, 2009 0.508 0.189 1.364 0.179 5 / 51 11 / 57 2.94
A Montejo et al, 2010 0.973 0.683 1.386 0.880 45 / 165 44 / 157 22.92
A Acosta-Escribano et al, 2010 1.794 1.127 2.855 0.014 31 / 54 16 / 50 13.26
A Singer et al, 2011 0.500 0.243 1.030 0.060 9 / 65 18 / 65 5.49
A Reignier et al, 2013 0.942 0.619 1.434 0.780 35 / 222 38 / 227 16.21
A 0.869 0.733 1.029 0.103
B Arabi et al, 2011 1.400 0.648 3.027 0.392 14 / 120 10 / 120 5.29
B Rice et al, 2011 0.810 0.426 1.537 0.518 14 / 98 18 / 102 7.65
B EDEN trial, 2012 1.086 0.691 1.707 0.721 37 / 508 33 / 492 15.35
B Charles et al, 2014 0.922 0.577 1.474 0.734 18 / 41 20 / 42 14.27
B Arabi et al, 2015 0.896 0.684 1.174 0.425 81 / 447 90 / 445 43.15
B Doig et al, 2015 0.731 0.457 1.169 0.190 25 / 166 34 / 165 14.28
B 0.914 0.766 1.092 0.323
Overall 0.890 0.788 1.006 0.062





Fig. 6 Pooled risk ratio with 95 % confidence interval (CI) for pneumonia associated with lower versus higher dose of enteral feeding. The
random effects model was used
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We note that in one of the included trials, the TICA-
COS trial [63], the difference in energy intake was largely
provoked by greater administration of PN rather than EN.
However, we included the study because it met our a
priori inclusion criterion; the mean enterally delivered en-
ergy in the study group was 1515 ± 756 kcal/day compared
with 1316 ± 456 kcal/day in the control group (p = 0.09),
which is more than 10 % [63]. We also note that in the in-
cluded INTACT trial [67], the number of days between
hospital admission and enrollment were 8.8 ± 8.7 and 6.4
± 6.6 days in the intensive medical and standard nutrition
groups, respectively (Table 1) and the caloric target was
30 kcal/kg in the intensive medical group. These issues
raised concerns about the occurrence of refeeding syn-
drome, which was not studied in the trial, and of overfeed-
ing in the intensive medical group which may have led to
early ICU deaths [67, 77–79].
The relationship between nutrition and infection risk
has been evaluated in different settings. A meta-analysis
found that EN versus PN was associated with a signifi-
cant decrease in infectious complications in critically ill
patients (relative risk 0.64, 95 % CI 0.47–0.87; p = 0.004)
[80]. Another meta-analysis found that EN within
24 hours after elective gastrointestinal surgery compared
with nil-by-mouth management reduced any infection
risk (relative risk 0.72, 95 % CI 0.54–0.98; p = 0.04) [81].
However, the impact of EN dose in critically ill patients is
not well-studied. In the current study, we have observed
that lower caloric intake was associated with lower noso-
comial blood stream infection risk. However, there was no
effect on total infections or pneumonia. This could be re-
lated to the heterogeneity of studies and publication bias.
Caloric restriction has been shown to be reno-protective
in animal models of acute kidney injury [82–84]. However,
a secondary analysis in the Randomized Evaluation of
Normal vs. Augmented Level of Replacement Therapy
trial found that the increased caloric intake was associated
with lower 90-day mortality on multivariable logistic
regression analysis (odds ratio per 100 kcal increment
0.95, 95 % CI 0.91–1.00; p = 0.06) on multivariable lo-
gistic regression analysis [85]. This was more pro-
nounced after excluding patients who died within
96 hours of ICU admission [85]. However, the mean cal-
oric intake during treatment was low (approximately 11 ±
9 kcal/kg/day). Our meta-analysis identified lower incident
renal replacement therapy rates in the lower calorie group,
but this finding is limited by the small number of studies
(n = 5) that reported on this outcome. Other possible
mechanisms for the difference in renal replacement
therapy, which may include differences in protein
I2 for Group A studies: 41.8%





Study name Statistics for each study Events / Total Risk ratio and 95% CI
Risk Lower Upper Relative 
ratio limit limit p-Value low high weight
A Singer et al, 2011 0.000 0.714 0.342 1.490 0.370 10 / 65 14 / 65 55.03
A Reignier et al, 20130.000 1.534 0.639 3.680 0.338 12 / 222 8 / 227 44.97
A 1.007 0.478 2.122 0.985
B Arabi et al, 2011 1.000 0.652 0.358 1.187 0.162 15 / 120 23 / 120 22.62
B Arabi et al, 2015 1.000 0.642 0.410 1.004 0.052 29 / 447 45 / 445 40.49
B Doig et al, 2015 1.000 0.731 0.457 1.169 0.190 25 / 166 34 / 165 36.89
B 0.676 0.508 0.898 0.007
Overall 0.711 0.545 0.928 0.012
0.01 0.1 1 10 100
Favors lower caloric 
intake
Favors higher caloric 
intake
Group A: Studies that did not test calorie restriction as an intervention. 
Group B: Studies that tested calorie restriction versus standard feeding strategy.
Regression of Log risk ratio on the difference in caloric intake  
Difference in caloric intake (kcal)  
Regression of Log risk ratio on the lower caloric intake  





Fig. 7 Incident renal replacement therapy. a Pooled risk ratio with 95 % confidence interval (CI) for incident renal replacement therapy, association
with lower versus higher dose of enteral feeding. The random effects model was used. b Meta-regression for the effect of the difference in calories
between the lower and higher caloric intake groups in each trial on incident renal replacement therapy. c Meta-regression for the effect of the caloric
dose in the lower caloric intake group in each trial on incident renal replacement therapy. d Funnel plot for the corresponding studies
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intake or fluid balance between the two groups, could
not be examined in our meta-analysis. Further studies
are needed to clarify this association.
Multiple observational and interventional studies have
identified variable associations between EN dose and
ICU and hospital LOS and mechanical ventilation dur-
ation [9, 12, 86–88]. Our meta-analysis did not identify
differences in mechanical ventilation duration or ICU
LOS. Lower caloric intake was associated with longer
hospital LOS in the subgroup of studies that compared
caloric restriction with standard feeding.
This study needs to be interpreted in the light of its
strengths and limitations. Potential confounders were
controlled for because of the randomized design of the
included trials. For example, age and severity of illness
were similar in the two arms in the included trials
(Table 1). A further strength is that rather than being se-
lective and possibly biased in selecting trials, we included
all studies in which a difference in enteral intake was pro-
voked by the intervention. As such we included not only
studies on caloric restriction but also studies evaluating
other interventions that affect caloric intake, such as gas-
tric residual volume management or small bowel feeding.
Such relatively wide inclusion criteria allowed the inclu-
sion of more trials. However, this strength may have pro-
voked a possible weakness. Studies were pooled despite
different design, some of them not even focused on
improving outcome by reaching feeding goals or by nutri-
ent restriction. We have addressed this limitation by
our subgroup analyses and by the meta-regression. Our
study focused on EN and did not include studies that
had PN as the primary intervention. Hence, the study
by Heidegger et al., in which ICU patients who received
<60 % of their calorimetry-calculated caloric target
from EN were randomized to either EN or EN plus
supplemental PN [89], was not included. Although sev-
eral studies showed similar outcomes with the two
routes [80, 90], we chose not to include PN trials as this
may further contribute to the heterogeneity. In
addition, permissive underfeeding in PN has been stud-
ied in earlier systematic reviews [8, 91].
Another limitation is related to the quality of the in-
cluded studies, most of which had one or more form of
bias. Furthermore, the caloric intake in all included stud-
ies in the higher feeding group was generally less than
the estimated caloric requirement. This is a reflection of
the difficulty in achieving full targets in cohorts of ICU
patients (although it certainly is achievable in many indi-
vidual patients). However, this resembles what has been
shown in many observational studies and in real-world
practice. Given that the full enteral intake was reached in
a few studies only, the benefit of this strategy remains un-
clear. While some studies calculated the calories from
sources other than EN and PN, such as intravenous
I2 for Group A studies: 25.8%
I2 for Group B studies: 57.1%
Overall I2: 76.3%
Group A: Studies that did not test calorie restriction as an intervention. 
Group B: Studies that tested calorie restriction versus standard feeding strategy.
Group by
Comparison
Study name Statistics for each study Difference in means and 95% CI
Difference Lower Upper Relative 
in means limit limit p-Value weight
Group A Kearns et al, 2000 4.000 -2.205 10.205 0.206 18.14
Group A Nguyen et al, 2007 -5.200 -8.698 -1.702 0.004 34.00
Group A Desachy et al, 2008 -5.000 -31.450 21.450 0.711 1.42
Group A Hsu et al, 2009 -4.300 -12.407 3.807 0.299 12.23
Group A Acosta-Escribano et al, 2010 3.000 -7.001 13.001 0.557 8.67
Group A Singer et al, 2011 -2.000 -10.662 6.662 0.651 11.00
Group A Braunschweig et al, 2015 -4.400 -11.645 2.845 0.234 14.53
Group A -2.239 -5.435 0.957 0.170
Group B Arabi et al, 2011 3.000 -22.422 28.422 0.817 1.38
Group B Charles et al, 2014 4.200 2.520 5.880 0.000 48.24
Group B Arabi et al, 2015 -6.100 -15.379 3.179 0.198 8.92
Group B Doig et al, 2015 6.200 3.769 8.631 0.000 41.46
Group B 4.094 1.075 7.113 0.008
Overall 1.108 -1.087 3.303 0.322
-8.00 -4.00 0.00 4.00 8.00
Meta Analysis
Favors lower caloric 
intake
Favors higher caloric 
intake
Fig. 8 Pooled risk ratio with 95 % confidence interval (CI) for hospital length of stay associated with lower versus higher dose of enteral feeding.
The random effects model was used
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I2 for Group A studies: 75.4%
I2 for Group B studies: 72.1%
Overall I2: 69.7%
Group A: Studies that did not test calorie restriction as an intervention. 




Study name Statistics for each study Difference in means and 95% CI
Difference Lower Upper Relative 
in means limit limit p-Value weight
Group A Montecalvo et al, 1992 1.200 -4.612 7.012 0.686 21.75
Group A Hsu et al, 2009 -4.700 -12.503 3.103 0.238 16.47
Group A Acosta-Escribano et al, 2010 1.600 0.061 3.139 0.042 34.58
Group A Singer et al, 2011 -5.600 -9.704 -1.496 0.007 27.19
Group A -1.483 -5.773 2.808 0.498
Group B Arabi et al, 2011 -2.600 -5.641 0.441 0.094 16.72
Group B Rugeles et al, 2013 -1.200 -3.283 0.883 0.259 23.70
Group B Arabi et al, 2015 -2.200 -4.438 0.038 0.054 22.42
Group B Doig et al, 2015 0.400 0.112 0.688 0.006 37.16
Group B -1.064 -2.732 0.605 0.212
Overall -1.119 -2.674 0.436 0.159





Fig. 10 Pooled risk ratio with 95 % confidence interval (CI) for the duration of mechanical ventilation associated with lower versus higher dose




Study name Statistics for each study Difference in means and 95% CI
Difference Lower Upper Relative 
in means limit limit p-Value weight
Group A Montecalvo et al, 1992 0.600 -5.497 6.697 0.847 3.28
Group A Kearns et al, 2000 -1.000 -2.183 0.183 0.098 44.63
Group A Desachy et al, 2008 0.000 -4.312 4.312 1.000 6.32
Group A Hsu et al, 2009 0.000 -4.103 4.103 1.000 6.92
Group A Montejo et al, 2010 -0.900 -4.398 2.598 0.614 9.25
Group A Acosta-Escribano et al, 2010 2.000 -1.116 5.116 0.208 11.35
Group A Singer et al, 2011 -5.500 -9.595 -1.405 0.008 6.95
Group A Huang et al, 2012 -0.300 -4.328 3.728 0.884 7.16
Group A Braunschweig et al, 2015 0.600 -4.795 5.995 0.827 4.14
Group A -0.662 -1.786 0.463 0.249
Group B Arabi et al, 2011 -2.800 -5.929 0.329 0.079 15.17
Group B Rugeles et al, 2013 -0.900 -3.203 1.403 0.444 18.33
Group B Charles et al, 2014 3.200 2.309 4.091 0.000 23.19
Group B Arabi et al, 2015 -0.600 -2.154 0.954 0.449 21.17
Group B Doig et al, 2015 1.400 0.138 2.662 0.030 22.15
Group B 0.335 -1.651 2.322 0.741
Overall -0.420 -1.398 0.559 0.400
-8.00 -4.00 0.00 4.00 8.00
I2 for Group A studies:11.7%
I2 for Group B studies: 87.6%
Overall I2: 78.0%
Group A: Studies that did not test calorie restriction as an intervention. 





Fig. 9 Pooled risk ratio with 95 % confidence interval (CI) for intensive care unit length of stay associated with lower versus higher dose
of enteral feeding. The random effects model was used
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dextrose (including medications) and propofol [14, 55, 63,
66–68], this was not a consistent approach among all tri-
als. Most included studies have used predictive equations
rather than indirect calorimetry to estimate caloric
intake. However, this is consistent with usual practice
in most ICUs, given the limited evidence supporting
either approach. Energy requirements were estimated
using different predictive formulae in all but one study,
which used indirect calorimetry [63]. This method has
been shown to poorly correlate with indirect calorim-
etry [92], which is considered to be the standard. Based
on recent evidence, calorimetry-guided nutrition might
be superior to predictive formula-based feeding in im-
proving patient-centered outcomes [63, 89].
The caloric dose and target varied among the included
studies and what was lower caloric intake in one study
was high in another. However, the meta-regression ana-
lysis suggested that the differences in calories between
groups and the amount of calories in the lower caloric
intake group did not influence hospital mortality. More-
over, not all studies reported on all the outcomes, thus
reducing the sample size used and the ability to find small
but potentially clinically significant effects. Given the re-
ported data in the individual studies, further analysis of
the impact of protein intake could not be performed.
Our systemic review highlights the limited data on this
important issue and calls for further studies on the im-
pact of protein intake on the outcomes of critically ill
patients. Our meta-analysis was not an individual-patient
meta-analysis and did not include economic or long-term
endpoints.
Conclusions
Lower versus higher dose of caloric intake in adult crit-
ically ill patients was not associated with differences in
mortality, risk of pneumonia or mechanical ventilation
duration. Lower caloric intake was associated with lower
risk of blood stream infections and incident renal replace-
ment. The great heterogeneity in the design, feeding route
and timing and caloric dose among the included trials
could limit the interpretation of the results of this system-
atic review and meta-analysis. Further studies are needed
to further evaluate the association between caloric intake
and renal replacement therapy in critically ill patients.
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